Pseudovirion-binding and neutralizing antibodies to cutaneous human papillomaviruses (HPV) correlated with the presence of HPV DNA in skin

Journal of General Virology

Volumn 94, Issue PART 5, 2013, Pages 1096-1103

  Faust, Helena ^a   Andersson, Kristin ^a   Forslund, Ola ^a   Dillner, Joakim ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GST L1 PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BLOOD SAMPLING; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 3; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 32; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 76; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOVIRION; SKIN; SKIN BIOPSY; VIRION; WART VIRUS;

EID: 84876204202     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.048561-0     Document Type: Article

References (34)

1. Andersson, K., Waterboer, T., Kirnbauer, R., Slupetzky, K., Iftner, T., de Villiers, E. M., Forslund, O., Pawlita, M. & Dillner, J. (2008). Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 17, 189-195.
2. Antonsson, A. (2012). Review: antibodies to cutaneous human papillomaviruses. J Med Virol 84, 814-822.
3. Buck, C. B., Pastrana, D. V., Lowy, D. R. & Schiller, J. T. (2004). Efficient intracellular assembly of papillomaviral vectors. J Virol 78, 751-757.
4. de Roda Husman, A. M., Snijders, P. J., Stel, H. V., van den Brule, A. J., Meijer, C. J. & Walboomers, J. M. (1995). Processing of longstored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72, 412-417.
5. de Villiers, E. M., Fauquet, C., Broker, T. R., Bernard, H. U. & zur Hausen, H. (2004). Classification of papillomaviruses. Virology 324, 17-27.
6. Dessy, F. J., Giannini, S. L., Bougelet, C. A., Kemp, T. J., David, M. P., Poncelet, S. M., Pinto, L. A. & Wettendorff, M. A. (2008). Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Hum Vaccin 4, 425-434.
7. Dias, D., Van Doren, J., Schlottmann, S., Kelly, S., Puchalski, D., Ruiz, W., Boerckel, P., Kessler, J., Antonello, J. M. & other authors (2005). Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 12, 959-969.
8. Dillner, J. (1999). The serological response to papillomaviruses. Semin Cancer Biol 9, 423-430.
9. Eklund, C., Unger, E. R., Nardelli-Haefliger, D., Zhou, T. & Dillner, J. (2012). International collaborative proficiency study of human papillomavirus type 16 serology. Vaccine 30, 294-299.
10. Faust, H., Knekt, P., Forslund, O. & Dillner, J. (2010). Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads. J Gen Virol 91, 1840-1848.
11. Favre, M., Majewski, S., Noszczyk, B., Maienfisch, F., Pura, A., Orth, G. & Jablonska, S. (2000). Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114, 403-407.
12. Feltkamp, M. C., de Koning, M. N., Bavinck, J. N. & Ter Schegget, J. (2008). Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 43, 353-360.
13. Forslund, O., Antonsson, A., Nordin, P., Stenquist, B. & Hansson, B. G. (1999). A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80, 2437-2443.
14. Forslund, O., Antonsson, A., Edlund, K., van den Brule, A. J., Hansson, B. G., Meijer, C. J., Ryd, W., Rylander, E., Strand, A. & other authors (2002). Population-based type-specific prevalence of highrisk human papillomavirus infection in middle-aged Swedish women. J Med Virol 66, 535-541.
15. Forslund, O., Lindelöf, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Slupetzky, K. & Dillner, J. (2004). High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol 123, 388-394.
16. Forslund, O., Iftner, T., Andersson, K., Lindelof, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Dillner, J., de Villiers, E. M. & Viraskin Study Group (2007). Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 196, 876-883.
17. Hagensee, M. E., Yaegashi, N. & Galloway, D. A. (1993). Selfassembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 67, 315-322.
18. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R. & Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 89, 12180-12184.
19. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R. & Schiller, J. T. (1994). A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86, 494-499.
20. Landis, J. R. & Koch, G. G. (1977). An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33, 363-374.
21. Michael, K. M., Waterboer, T., Sehr, P., Rother, A., Reidel, U., Boeing, H., Bravo, I. G., Schlehofer, J., Gärtner, B. C. & Pawlita, M. (2008). Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4, e1000091.
22. Newall, A. T., Brotherton, J. M., Quinn, H. E., McIntyre, P. B., Backhouse, J., Gilbert, L., Esser, M. T., Erick, J., Bryan, J. & other authors (2008). Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis 46, 1647-1655.
23. Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N. & Esser, M. T. (2003). Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 10, 108-115.
24. Opalka, D., Matys, K., Bojczuk, P., Green, T., Gesser, R., Saah, A., Haupt, R., Dutko, F. & Esser, M. T. (2010). Multiplexed serologic assay for nine anogenital human papillomavirus types. Clin Vaccine Immunol 17, 818-827.
25. Paaso, A. E., Louvanto, K., Syrjänen, K. J., Waterboer, T., Grénman, S. E., Pawlita, M. & Syrjänen, S. M. (2011). Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. J Gen Virol 92, 2034-2046.
26. Pastrana, D. V., Buck, C. B., Pang, Y. Y., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Krüger Kjaer, S., Lowy, D. R. & Schiller, J. T. (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321, 205-216.
27. Plasmeijer, E. I., Neale, R. E., O'Rourke, P., Mallitt, K. A., de Koning, M. N., Quint, W., Buettner, P. G., Pawlita, M., Waterboer, T. & other authors (2010). Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 91, 2073-2079.
28. Rizk, R. Z., Christensen, N. D., Michael, K. M., Müller, M., Sehr, P., Waterboer, T. & Pawlita, M. (2008). Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol 89, 117-129.
29. Schiller, J. T. & Lowy, D. R. (2009). Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J Infect Dis 200, 166-171.
30. Sehr, P., Zumbach, K. & Pawlita, M. (2001). A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253, 153-162.
31. Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C. & other authors (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6, 271-278.
32. Waterboer, T., Sehr, P., Michael, K. M., Franceschi, S., Nieland, J. D., Joos, T. O., Templin, M. F. & Pawlita, M. (2005). Multiplex human papillomavirus serology based on in situ-purified glutathione Stransferase fusion proteins. Clin Chem 51, 1845-1853.
33. Waterboer, T., Sehr, P. & Pawlita, M. (2006). Suppression of nonspecific binding in serological Luminex assays. J Immunol Methods 309, 200-204.
34. zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350.